Skip to main content

Want a detailed portfolio tracker?

PMV Pharmaceuticals (PMVP) P/E (2020 - 2026)

PMV Pharmaceuticals (PMVP) P/E from Sep 25, 2020 to Jul 21, 2026. The TTM PMV Pharmaceuticals (PMVP) P/E is -0.89. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of PMV Pharmaceuticals (PMVP)

YearP/EChange
2026-0.89+4.62%
2025-0.85-36.17%
2024-1.33-33.74%
2023-2.01-63.35%
2022-5.48-69.68%
2021-18.07-74.48%
2020-70.82N/A

Comparison PMV Pharmaceuticals (PMVP) P/E with competitors

PMV Pharmaceuticals (PMVP) P/E is -0.89.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.19%
NBYStablecoin Development Corp0.00-100.48%
ENLVEnlivex Ltd0.07-108.42%
FGENFibroGen Inc0.24-127.01%
CHRSCoherus Biosciences Inc0.85-195.48%
FBIOFortress Biotech Inc0.95-206.79%
ORMPOramed Pharmaceuticals Inc1.50-269.14%
AGENAgenus Inc3.01-438.66%
INVAInnoviva Inc3.15-454.91%
VXRTVaxart Inc3.55-499.44%
CRMDCorMedix Inc3.63-508.30%
CVACCureVac N.V.4.45-600.26%
GLPGGalapagos NV4.86-646.76%
SRPTSarepta Therapeutics Inc4.88-649.37%
ABEOAbeona Therapeutics Inc5.39-706.24%
ABUSArbutus Biopharma Corp5.60-729.66%
ZVRAZevra Therapeutics Inc5.89-762.48%
SPROSpero Therapeutics Inc6.23-800.87%
CGENCompugen Ltd6.31-810.49%
RIGLRigel Pharmaceuticals6.87-873.30%
SLXNSilexion Therapeutics Corp7.30-921.01%
OMEROmeros Corporation9.26-1141.87%
AUPHAurinia Pharmaceuticals Inc9.58-1178.57%
ACADAcadia Pharmaceuticals Inc11.73-1419.79%
TBPHTheravance Biopharma Inc12.26-1479.83%
ADMAAdma Biologics Inc12.42-1497.39%
HRMYHarmony Biosciences Holdings Inc13.82-1655.16%
SABSSAB Biotherapeutics Inc14.14-1690.72%
NAGENiagen Bioscience Inc14.82-1767.45%
INCYIncyte Corp15.82-1880.48%
REGNRegeneron Pharmaceuticals Inc15.86-1884.32%
PBYIPuma Biotechnology Inc17.32-2048.50%
CPRXCatalyst Pharmaceuticals Inc17.44-2062.41%
EXELExelixis Inc17.54-2073.52%
TGTXTG Therapeutics Inc18.97-2234.21%
MDXGMimedx Group Inc20.55-2412.73%
XOMAXOMA Royalty Corp22.87-2674.11%
ARGXArgen X SE24.30-2834.28%
CTMXCytomX Therapeutics Inc24.82-2893.14%
XOMAOXOMA Royalty Corp25.34-2952.08%
HALOHalozyme Therapeutics Inc25.62-2983.46%
XOMAPXOMA Royalty Corp25.67-2988.68%
VRTXVertex Pharmaceuticals Inc27.99-3250.28%
RPRXRoyalty Pharma plc - Class A28.69-3328.24%
SLNOSoleno Therapeutics Inc29.02-3365.13%
ASNDAscendis Pharma A/S30.09-3485.56%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4366.28%
APLSApellis Pharmaceuticals Inc39.02-4491.10%
BMRNBiomarin Pharmaceutical Inc42.21-4850.14%
KRYSKrystal Biotech Inc45.34-5202.55%
ONCBeiGene Ltd69.54-7925.46%
PHARPharming Group N.V.75.03-8542.71%
TECHBio-Techne Corp101.96-11573.49%
VCELVericel Corp109.92-12469.57%
ALNYAlnylam Pharmaceuticals Inc117.96-13374.74%
GMABGenmab140.29-15887.08%
TLXTelix Pharmaceuticals Ltd162.15-18347.24%
CORTCorcept Therapeutics Inc212.86-24053.09%